DRAP Issues Recall Alert for Substandard Pain Relief Injection

DRAP Issues Recall Alert for Substandard Pain Relief Injection

The Drug Regulatory Authority of Pakistan (DRAP) has issued a recall alert for an injection used for pain relief. The recall alert was issued after the drug was declared as substandard by the Central Drugs Laboratory (CDL) in Karachi.

According to details, the batch number “23E018” of Artecid 75mg/3mL Injection, manufactured by M/s. Biolabs (Private) Limited, Islamabad, was found to contain an unaccepted level of Ethylene Glycol impurity.

It is pertinent to mention that the Ethylene Glycol is a toxic substance that can have serious health complications. It can affect the central nervous system, heart can also cause kidney damage, which can be fatal.

Read More: FACT CHECK: Viral Video alleging army helicopters used for crop drying exposed as propaganda

DRAP has directed the M/s. Biolabs (Private) Limited to immediately recall the batch number “23E018” of Artecid 75mg/3mL Injection from the market. Furthermore, pharmacists and chemists at distributions and pharmacies have been ordered to check their stock and immediately halt the supply of this product.

editor

Related Articles

1 Comment

Avarage Rating:
  • 0 / 10

Leave a Reply

Your email address will not be published. Required fields are marked *